Multiple Myeloma is a blood cancer that can cause symptoms such as fatigue, bone pain and/or kidney problems.
Over 50% of Myeloma patients go to their primary care physician with vague symptoms. Often these patients are not diagnosed for more than 6 months allowing the cancer to damage bones and kidneys.
Detecting Myeloma earlier means fewer patients with extensive damage to their bones and kidneys and longer survival. The tests recommended for detection of Myeloma are Serum Protein Electrophoresis (SPE or SPEP), Serum Immunofixation and Freelite.
These three tests together will detect 99% of myeloma cases. With earlier detection, patients can be monitored or treated more quickly to improve their quality of life (fewer bone and kidney problems) and increase their chances of long term survival.